INTRODUCTION
The first human polyomavirus was discovered in 1971 from the brain tissue of a patient with Hogkins' lymphoma and progressive multifocal leukoencephalopathy (PML). It was named after the patients initials: John Cunningham. Because polyoma viruses are common global viruses, they cause various infections in many mammalian species, including humans. Fifteen polyomaviruses are currently known. The best-known viruses of this kind are BKPyV and JCPyV [1, 2] .
In immunocompetent individuals, clinically relevant infections seldom occur, only with a weakened immune system can their reactivation happen. However, primary infections are usually asymptomatic, and it is estimated that more than 80% of the entire adult population have detectable antibodies against polyomavirus JC [3] . After infection, the viruses persist in the cells for the entirety of life [3, 4] Polyomaviruses are common viruses that induce various infections in many mammalian species, including humans. The best-known viruses of this kind are BKV and JCV. The aim of the study was to analyze the incidence of infection caused by JCV in a group of patients after kidney or bone marrow transplant, and to analyze JCV genetic diversity in post-transplantation recipients. The study group included 81 patients after kidney transplantation treated in the Independent Public Teaching Hospital No 4 in Lublin and a group of 24 patients after marrow transplantation from the Children's Clinical Hospital of Lublin. The research material included 105 DNA probes from urine samples that were tested via the PCR method for the presence of JCV genetic material. Amplification products were separated in agarose gel, positive PCR products were subjected to purification and the pure product was sent to sequencing. Pearson's chi-square test was used to investigate the relationship between the prevalence of JCV viruria and study group and gender. Statistical significance was defined as p < 0.05. A JCV positive result was discovered in 27.6% of all samples. In the group of adults, 34.6% were positive, while in children, this was 3.4%. Among all patients, only 8 women were infected with the JC virus, while 21 men were. We saw that the incidence of infection caused by the JC virus increases with age. Moreover, JCV DNA is more frequently isolated from men than from women. JCV infections are also a more common cause of infections in patients after renal transplantation than in bone marrow transplant patients.
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The aim of the study was to analyze the incidence of infection caused by JC virus and BK virus in a group of patients after kidney or bone marrow transplant, and to analyze JCV genetic diversity in post-transplantation recipients with reactivation of infection due to JC virus.
MATERIALS AND METHOD
The study group included 105 patients, 81 after kidney transplantation (adults -41 men and 32 women) treated in the Independent Public Teaching Hospital No 4 in Lublin, and a group of 24 patients (children -7 boys and 17 girls) after marrow transplantation from the Children's Clinical Hospital of Lublin. Among adults, the average age was 47 years and among children, the corresponding figure is 10 years. The research material included DNA isolated from the urine samples obtained from 105 patients during immunosuppressive therapy ( Urinary isolates were tested via the PCR method for the presence of the genetic material of the JC virus. The size of product was 215 bp. The primer sequences are: JLP-15 -5′ ACA GTG TGG CCA GAA TTC ACT ACC 3′; JLP-16 -5′ TAA AGC CTC CCC CCC AAC AGA AA 3′.
All PCR reactions were carried out in the final volume of 20 μl using a PCR Core Kit (Qiagen, Hilden, Germany). The reaction mixture included: water for PCR -11.3 μl; 10 × bufor PCR with 15 mM MgCl 2 -2 μl; dNTPs -0.4 μl; primer JLP-15 -0.6 μl; primer JLP-16 -0.6 μl; Tag polymerase -0,1 μl. The reaction mixture containing 5 μl of extracted DNA was amplified in a Sensoquest thermocycler under the following conditions: 95°C for 3 min. of initial denaturation then 40 cycles of 94°C for 60 s., 62°C for 90 s., 72°C for 60 s., with final extension at 72°C for 10 min. Amplification products are separated in a 2% agarose gel at 96V for about 30 minutes. A DNA band size of 215 bp was observed under UV light.
Positive PCR products, made visible during electrophoresis, were subjected to purification via Amicon Ultra-0.5 (Millipore) column, to remove free dNTPs and the excess of primers. The pure product was sent for sequencing to Genomed, to determine the genotype. Next, a phylogenetic similarity analysis was performed of the obtained strains.
Descriptive statistics were used to characterize patient baseline characteristics. Pearson's chi-square test was used to investigate the relationship between the prevalence of JCV viruria and study group and gender. Statistical significance was defined as p < 0.05.
RESULTS

Occurrence of JCV in the study group
The study group consisted of 105 DNA probes, positive results were discovered in 29 of them (27.6%) and negative results in 76 (72.4%). In the adult group, 34.6% were positive, while in children's group, 3.4% were positive. Among all patients, only 8 women were found to be infected with the JC virus, while 21 men were (p=0.015). A significant association was found between the prevalence of viruria JC and the study group (Table 2) .
Tables 2. Prevalence of JCV infections depending on age and gender
Positive results
Negative results p n % n % 
Sequence analysis of the PCR product
The JC virus genotypes were identified by way of the PCR product sequence analysis (VP1 gene fragment with the length of 215 bp) that had been performed in 23 patients. Of the patients who were diagnosed with JC virus reactivation, 91% had genotype 1A, while 9% had 1B. These genotypes were distinguished through positions 1843 and 1849. Table 3 provides a comparison of the JC virus genotypes sequences derived from infected patients. Depending on the subtype, a prototype sequence was determined which was identifiable at specific positions in the reference sequence of the viral genome. The underlined nucleotides in the prototype sequence enable the distinguishing of 1A from the 1B subtype (for 1A, subtype G occurs at position 1843, and for 1B, this is subtype T, while at position 1849, A is found for subtype 1A and G for 1B). The positions in the virus genome which do not affect the genotype type, are underlined. Type  1753  1771  1786  1795  1804  1818  1822  1836  1837  1843  1849  1850  1851 1869 1870
Tables 3. Differences in the sequences JCV genotypes
JC virus is becoming more widespread in the world's population, and it can bring about dangerous kidney infection that can lead to progressive multifocal leukoencephalopathy, characterized by demyelination of the nerve tissue of the nervous system [10, 11] .
In this study, JCV was detected in 27.6% of all test patients. Other studies of transplant patients and normal population have observed a JCV prevalence between 9.5-38% [12, 13, 14] . Indeed, Boukoum et al. [13] detected JCV viruria in 13% of all healthy individuals, but in 38% of all kidney transplant recipients in their test population. In Saundh et al. [14] , JCV was indicated in 15 of 112 cases (13.3%). There was no significant differences observed between control and study groups. Boukoum et al. [12] in their analysis of occurrence polyomaviruses, noted that JCV was detected in 9.5% of all urine samples, whereas JCV was not detected in plasma.
Kmieciak et al. [9] in their studies on the prevalence of the JCV DNA load in normal donors, showed an increase of infection with age. They carried out their tests utilizing the PCR method by amplifying a fragment of 215 bp from the region of the VP1 protein gene. On examining a Polish group of 113 people, they saw that 46% (52/113) of the test population were infected with the JC virus. Moreover, most infections were detected in people older than 60 years (63.6%), which may indicate possible reactivation of the virus in the later period of life when the human body, even in healthy people, is already weakened. Furthermore, through determining the JCV genotype by analysis of the VP1 gene fragment sequence obtained from infected persons, they showed a significant prevalence of subtype 1A -59.6% (31/52), while the second most prevalent genotype was 1B -25% (13/52), the third was 2 C -11.5% (6/52), and the fourth was 2A -3.8% (2/52).
Such incidence and distribution of JCV genotypes in the Polish population confirms the fact that in European countries, including Poland, genotype 1 is the one most common. The results obtained by Kmieciak et al. are similar to that obtained in this study, where the 1A genotype subtype prevailed. Their study, however, did not see genotype 4, although it is the second most common in Europe. This result may be due to the geographical area from which the test samples came.
In comparing incidence of infection, Kmieciak et al. reported that 46% of all healthy donors were infected, while the results obtained in our research showed a lesser virus load detection -27.6%. This may be related to a smaller number of samples from people over 61 years of age (12 persons) than in the above mentioned study (22 persons). Due to the possibility of JCV infection in childhood (almost 80% of the world's population is infected), when the infection can pass without symptoms, but anti-JCV antibodies are produced, which indicate an infection, the virus remains in a latent form. With decreased immunity, it can be reactivated and engender PML. The detection of viral DNA in the urine can occur not only during the disease, but also during other viral infections or during pregnancy. These effects could explain the very high detection of JCV DNA in healthy subjects by Kmieciak et al. [9] .
The low incidence of JCV infections in children (4%) can be observed in the analysis of the tests carried out on samples from patients hospitalized due to a bone marrow transplant. This effect is confirmed by research conducted by Agostini et al. [15] , Kmieciak et al. [9] and Dubois et al. [16] . This can be explained by the young age of the patients (the average age of this study subjects was 10 years). Indeed, the majority of such children have not yet had contact with the JCV virus, therefore, virus reactivation does not occur after administration of immunosuppressive drugs. This hypothesis can be checked via additional research on the anti-JCV antibodies prevalence.
Agostini et al. 2001 [15] conducted a survey on a group of 350 patients from four countries, including Poland, assessing JCV genotype kind and the incidence of JC virus infection. The study groups included adults aged 13-95 -191 women and 159 men. Patients from Poland accounted for 59 of these individuals -of which 52% were male (29/56) and 48% were female (27/56). Using the PCR method with primers JLP-15 and JLP-16, they detected the JCV DNA load, and then they conducted a sequencing of the products obtained to determine the genotype of the detected virus. Of 350 respondents, JCV infection was detected in 153, which represents 44% of the study population. With regard to the Polish patients alone, the JCV DNA load was detected in 22 patients, which in relation to the Polish study group, gives a figure of 39% (22/56). After the analysis of the genotypes, a clear dominance of type 1 was observed, in that 1B subtype had prevalence (62/153) over 1A (53/153), while the remaining genotypes were obtained in following quantities: 33 of subtype 4 (33/153), 3 subtypes 2B (3/153), 1 subtype 2A (1/153) and 1 subtype 3A (1/153). Referring to the Polish group alone, 1A subtype of the virus was the most prolific (11/56), then 1B (7/56) and subtype 4 (4/56). The research revealed the significant preponderance of JC virus genotype 1 in Europe, thus, in Poland [15] .
Our study is also indicative of the predominant occurrence of type 1 in Poland. The proportion of genotype 1A received in the examined subjects was 91%, which is almost twice higher than the incidence of this genotype in the Polish group studied by Agostini et al. [15] , where the proportion was 50%. Among the sequences analyzed, the 1B subtype represented 9%, and the incidence of JC virus infection was 27.6% of all the patients tested, which in respect of the results presented above (39%), indicates a worrisome degree of JCV infection among hospitalized patients.
A similar probability of virus migration was demonstrated by Agostini et al. [7] . They conducted a study which compared the genotypes of JC virus in groups of indigenous people in Navajo, Flathead and Chamorro. The three studied populations are ethnic groups from Asia (dating back many thousands of years) and are recognized as Native Americans. Using the PCR method, the researchers revealed the presence of JCV DNA load in 66% of all the Navaho, After further analysis of the viral DNA by sequencing, they were able to identify individual genotypes. The vast majority: 56-68% of all JCV strains obtained from the three populations belongs to the Asian genotype -2A.
Current Issues in Pharmacy and Medical Sciences
The fact that the main type of JC virus occurring in the United States represents genotype 1 (European), while 2A and 2B originate from Asia, suggests that the prevalence of genotype 2A among Native Americans has an Asian origin. This would indicate that infection of the US population with JC virus occurred earlier than did Native American contact with the population from Europe, and that it precedes the [modern time] migration of these people from Asia to America. Because the virus strains as infectious diseases, move within particular social groups through their mass movement, they allow the tracking of human migration patterns around the world. This is a confirmation of the fact that JC virus is a good marker of current and prehistoric human migration [17] .
Moreover, the polyomavirus has evolved relatively rapidly in comparison with the human genome, but slowly, in contrast to the infectious RNA viruses, and, therefore, is more applicable as a marker. Of note, the essence of a good quality migration marker is its genetic stability, which is typical for JCV as a DNA virus [10, 17] .
CONCLUSIONS
The incidence of infection caused by the JC virus increases with age. JCV DNA is more frequently isolated from men than from women. JCV infections are more common causes of infections in patients after renal transplantation than in bone marrow transplant patients. Virus genotype 1 alone occurred in the study population, with a significant dominance of subtype 1A over 1B, which confirms that genotype 1 is the most common in Europe.
